HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Fiscal 2009 Spending Bill Will Likely Need to Wait For Next Administration

This article was originally published in The Rose Sheet

Executive Summary

House Democratic leaders are signaling an intention to put off finalizing fiscal 2009 appropriations at least until next March, charging Republican members of Congress and the Bush administration are impeding negotiations on mutually agreeable bills

You may also be interested in...



Omnibus Funding Bill Includes $1 Mil. Boost For FDA’s Cosmetics Office

Members of Congress want detailed quarterly updates from FDA on how the agency uses its 2009 appropriation, which includes a $1 million increase for the Office of Cosmetics and Colors, according to a joint explanatory statement accompanying the omnibus spending bill

Omnibus Funding Bill Includes $1 Mil. Boost For FDA’s Cosmetics Office

Members of Congress want detailed quarterly updates from FDA on how the agency uses its 2009 appropriation, which includes a $1 million increase for the Office of Cosmetics and Colors, according to a joint explanatory statement accompanying the omnibus spending bill

Additional FDA funds

FDA receives $150 million in additional funding for fiscal 2008 in the Supplemental Appropriations Bill of 2008, H.R. 2642, signed June 30 by President Bush. The appropriation includes $66.8 million for the Center for Food Safety and Applied Nutrition, which houses the Office of Colors and Cosmetics, $28 million for the Center for Drug Evaluation and Research and $12.7 million for the Center of Biologics Evaluation and Research. In an effort led by Pennsylvania Republican Arlen Specter, the Senate initially approved giving FDA $275 million in additional fiscal 2008 funding, but the administration vowed to veto those elevated spending levels. FDA received a $1 million increase dedicated to cosmetics oversight in fiscal 2008 in an omnibus bill passed in January (1"The Rose Sheet" Jan. 7, 2008, p. 5). House appropriators now are looking for progress on fiscal 2009 appropriations despite partisan differences (see 2related story)...

Latest Headlines
See All
UsernamePublicRestriction

Register

RS015524

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel